Literature DB >> 233969

Concanavalin A inhibits tissue factor coagulant activity.

F A Pitlick.   

Abstract

Concanavalin A (con A) is a potent inhibitor of coagulant activity of native tissue factor. Coagulant activity is recovered by addition of alpha-methyl-D-glucoside to inhibited tissue factor. Inclusion of alpha-methyl-D-glucose during incubation of con A with tissue factor preserves coagulant activity. These data suggest that con A interacts reversibly with a carbohydrate residue in such a way as to inhibit coagulant activity of the molecule. Purified tissue factor apoprotein has been recombined with mixed brain phospholipids or purified phospholipids (phosphatidyl ethanolamine or a mixture of phosphatidyl choline with phosphatidyl serine). These preparations were also completely but reversibly inhibited by con A. Thus, purified tissue factor apoprotein appears to donate the affected carbohydrate residue.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 233969      PMCID: PMC301729          DOI: 10.1172/JCI107908

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A difference in the architecture of the surface membrane of normal and virally transformed cells.

Authors:  M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

2.  An assay for coagulation factor VII using factor VII-depleted bovine plasma.

Authors:  Y Nemerson; L P Clyne
Journal:  J Lab Clin Med       Date:  1974-02

3.  Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X.

Authors:  J Jesty; Y Nemerson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

4.  Accessibility of the carbohydrate moiety of rhodopsin.

Authors:  A Steinemann; L Stryer
Journal:  Biochemistry       Date:  1973-04-10       Impact factor: 3.162

5.  Activation of the coagulation factor VII by tissue thromboplastin and calcium.

Authors:  B Osterud; A Berre; A B Otnaess; E Bjorklid; H Prydz
Journal:  Biochemistry       Date:  1972-07-18       Impact factor: 3.162

6.  Protein-carbohydrate interaction. VI. Isolation of concanavalin A by specific adsorption on cross-linked dextran gels.

Authors:  B B Agrawal; I J Goldstein
Journal:  Biochim Biophys Acta       Date:  1967-10-23

7.  Purification and characterization of the protein component of tissue factor.

Authors:  Y Nemerson; F A Pitlick
Journal:  Biochemistry       Date:  1970-12-22       Impact factor: 3.162

8.  Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor.

Authors:  Y Nemerson; M P Esnouf
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

9.  Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A.

Authors:  F R Rickles; J A Hardin; F A Pitlick; L W Hoyer; M E Conrad
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

10.  Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells.

Authors:  M Inbar; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

View more
  14 in total

1.  Tissue factor purified from different cellular sources and non-glycosylated tissue factor show similar procoagulant activity.

Authors:  H Kothari; U R Pendurthi; L V M Rao
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

2.  Purification and some properties of the protein component of tissue thromboplastin from human brain.

Authors:  E Bjorklid; E Storm
Journal:  Biochem J       Date:  1977-07-01       Impact factor: 3.857

Review 3.  [Biology of lectins and their application in clinical biochemistry (author's transl)].

Authors:  E Köttgen
Journal:  Klin Wochenschr       Date:  1977-04-15

4.  Glycosylation of tissue factor is not essential for its transport or functions.

Authors:  H Kothari; L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

5.  Blockade by ruthenium red of tissue factor-initiated coagulation.

Authors:  A J Chu; Z G Wang; O I Nwobi; S Beydoun
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 6.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

Authors:  Sara C Sebag; Julie A Bastarache; Lorraine B Ware
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

7.  Carbohydrates and activity of natural and recombinant tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Kenneth G Mann; Saulius Butenas
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

8.  DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formation.

Authors:  B Casali; M G Lampugnani; M Riganti; A Niewiarowska; G Alessio; L Mussoni; N Semeraro; M B Donati
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

Review 9.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

10.  Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test.

Authors:  M Iitaka; J Bernstein; H C Gerstein; Y Iwatani; V V Row; R Volpé
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.